About
Our Story
From a clinical conviction to a regulated PCR manufacturer serving the Kingdom and the region.
Gene Matrix began with a question asked across Saudi clinics during the pandemic years: why does a Kingdom of more than 35 million people rely almost entirely on imported diagnostics for cancer screening, sexual health, and infectious-disease surveillance?
That question, repeated across hospital corridors, public-health units, and laboratory benches, became the founding brief for Gene Matrix — a dedicated, in-Kingdom manufacturer of multiplex PCR diagnostics, built for the realities of Saudi clinical practice and aligned with Vision 2030's health-sector strategy.
Timeline
Two decades, one trajectory
- 1
Two decades earlier
Clinical & molecular foundations
Dr. Burhan Fakhurji's career across medicine, molecular biology and laboratory leadership in Saudi Arabia builds the conviction behind Gene Matrix.
- 2
1,000+ trained
Building national laboratory capacity
Years of training Saudi healthcare professionals in molecular techniques creates the human-capital base for in-Kingdom diagnostics manufacturing.
- 3
Pandemic years
The question that started Gene Matrix
A Kingdom of 35 million people depending almost entirely on imported diagnostics — for cancer screening, STI surveillance and outbreak response — is a strategic vulnerability.
- 4
Site selection
Modon Oasis, Jeddah
A purpose-built 700 m² Good Manufacturing Practice facility is established in Jeddah's industrial zone — designed around an ISO 5 (Grade A) cleanroom inside an ISO 7 (Grade C) background.
- 5
Phase 1 portfolio
Four flagship PCR kits
HPV (14 high-risk genotypes), STI 12-Panel, Dengue (DENV 1–4) and Colorectal & Pancreatic ctDNA — selected to address the Kingdom's most pressing clinical and public-health priorities.
- 6
Today
A national capability, openly building
Operating under a regulated quality system aligned with SFDA · ISO 13485 · WHO GMP, Gene Matrix is engaging hospitals, distributors and tech-transfer partners across the GCC and MENA.
Gene Matrix is more than a manufacturer. It is a contribution to national health sovereignty — a deliberate step toward a future where critical diagnostics are designed, validated, and produced at home.